250 related articles for article (PubMed ID: 21269698)
1. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
Kulik L; Chen K; Huber BT; Holers VM
Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
[TBL] [Abstract][Full Text] [Related]
2. A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
Kulik L; Hewitt FB; Willis VC; Rodriguez R; Tomlinson S; Holers VM
Mol Immunol; 2015 Feb; 63(2):479-88. PubMed ID: 25457881
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development.
Kulik L; Marchbank KJ; Lyubchenko T; Kuhn KA; Liubchenko GA; Haluszczak C; Gipson MG; Boackle SA; Holers VM
Eur J Immunol; 2007 Mar; 37(3):623-33. PubMed ID: 17301948
[TBL] [Abstract][Full Text] [Related]
4. Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function.
Marchbank KJ; Watson CC; Ritsema DF; Holers VM
J Immunol; 2000 Sep; 165(5):2354-61. PubMed ID: 10946257
[TBL] [Abstract][Full Text] [Related]
5. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
[TBL] [Abstract][Full Text] [Related]
6. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
7. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
[TBL] [Abstract][Full Text] [Related]
8. B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens.
Birrell L; Kulik L; Morgan BP; Holers VM; Marchbank KJ
J Immunol; 2005 Jun; 174(11):6974-82. PubMed ID: 15905540
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways.
Bouillie S; Barel M; Drane P; Cassinat B; Balbo M; Holers VM; Frade R
Eur J Immunol; 1995 Sep; 25(9):2661-7. PubMed ID: 7589142
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction.
Gustavsson S; Kinoshita T; Heyman B
J Immunol; 1995 Jun; 154(12):6524-8. PubMed ID: 7759885
[TBL] [Abstract][Full Text] [Related]
11. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL.
Delibrias CC; Fischer E; Bismuth G; Kazatchkine MD
J Immunol; 1992 Aug; 149(3):768-74. PubMed ID: 1386093
[TBL] [Abstract][Full Text] [Related]
12. Impaired antibody responses but normal proliferation of specific CD4+ T cells in mice lacking complement receptors 1 and 2.
Carlsson F; Getahun A; Rutemark C; Heyman B
Scand J Immunol; 2009 Aug; 70(2):77-84. PubMed ID: 19630912
[TBL] [Abstract][Full Text] [Related]
13. Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3.
Twohig J; Kulik L; Haluszczak C; Reuter J; Rossbach A; Bull M; Holers VM; Marchbank KJ
Mol Immunol; 2007 Jul; 44(13):3434-44. PubMed ID: 17379312
[TBL] [Abstract][Full Text] [Related]
14. Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice.
Twohig JP; Pappworth IY; Sivasankar B; Kulik L; Bull M; Holers VM; Wang EC; Marchbank KJ
Mol Immunol; 2009 Jun; 46(10):2002-13. PubMed ID: 19359041
[TBL] [Abstract][Full Text] [Related]
15. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
Luxembourg AT; Cooper NR
J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.
Imai M; Ohta R; Varela JC; Song H; Tomlinson S
Cancer Res; 2007 Oct; 67(19):9535-41. PubMed ID: 17909064
[TBL] [Abstract][Full Text] [Related]
17. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo.
Thyphronitis G; Kinoshita T; Inoue K; Schweinle JE; Tsokos GC; Metcalf ES; Finkelman FD; Balow JE
J Immunol; 1991 Jul; 147(1):224-30. PubMed ID: 1828822
[TBL] [Abstract][Full Text] [Related]
18. Low doses of antigen coupled to anti-CR2 mAbs induce rapid and enduring IgG immune responses in mice and in cynomolgus monkeys.
Whipple EC; Ditto AH; Shanahan RS; Gatesman JJ; Little SF; Taylor RP; Lindorfer MA
Mol Immunol; 2007 Jan; 44(4):377-88. PubMed ID: 16631928
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
[TBL] [Abstract][Full Text] [Related]
20. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
Sato S; Miller AS; Howard MC; Tedder TF
J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
